Yingming Wang

Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease.

Wenyuan Liu, F. Feng, Haopeng Sun, 2020, Bioorganic & medicinal chemistry.

Specific-oxygen-supply functionalized core-shell nanoparticles for smart mutual-promotion between photodynamic therapy and gambogic acid-induced chemotherapy.

H. Pang, Wenyuan Liu, F. Feng, 2020, Biomaterials.

A stage-specific cancer chemotherapy strategy through flexible combination of reduction-activated charge-conversional core-shell nanoparticles

Wenyuan Liu, F. Feng, Wei Qu, 2019, Theranostics.

Targeted degradation of anaplastic lymphoma kinase by gold nanoparticle-based multi-headed proteolysis targeting chimeras.

Wenyuan Liu, F. Feng, Fu-Rong Yang, 2020, Colloids and surfaces. B, Biointerfaces.

Computational design of binder as the LC3-p62 protein-protein interaction.

Wenyuan Liu, F. Feng, Haopeng Sun, 2021, Bioorganic chemistry.

Anti-cancer adjuvant drug screening via epithelial-mesenchymal transition-related aptamer probe

Wenyuan Liu, Huai-Song Wang, Congcong Gu, 2021, Analytical and Bioanalytical Chemistry.

A stage-specific cancer chemotherapy strategy through 1 flexible combination of reduction-activated charge-2 conversional core-shell nanoparticles 3 4

Wenyuan Liu, F. Feng, Wei Qu, 2019 .